监督的有氧强度运动减少了姿势摇摆,改善了帕金森病患者的双重任务步态
Pavol Martiš1, Diana Bzdúšková2, Zuzana Košutzká1
1Second Department of Neurology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
Scientific reports
|July 2, 2025
概括
在帕金森病 (PD) 患者中,有监督的有氧强度运动改善了平衡和步态,特别是在OFF药物治疗时. 这种训练增强了双重任务行走性能和姿势稳定性,提供了超越标准利沃多巴治疗的好处.
科学领域:
- 神经学 神经学
- 运动科学 运动科学
- 康复医学 康复医学 康复医学
背景情况:
- 帕金森病 (PD) 显著影响平衡,步态和生活质量,而勒沃多巴在姿势不稳定方面提供有限的益处.
- 运动训练为管理PD症状和改善运动功能提供了一个互补的方法.
研究的目的:
- 为了研究4个月监督的有氧强度炼计划对PD患者的姿势稳定性和步态的影响.
- 分析药物开启和关闭状态之间的运动诱导改善的差异.
- 检查正常行走和双重任务行走期间静态和动态平衡之间的关系.
主要方法:
- 15名PD患者接受了为期4个月的监督有氧强度运动干预.
- 干预前后的评估包括静态平衡的行李箱加速度计和动态平衡的无标记摄像头系统.
- 在药物ON和OFF状态下进行了评估,使用MDS-统一帕金森病评级表 (MDS-UPDRS) 和Berg平衡表 (BBS).
主要成果:
- 在干预后,在开启和关闭药物状态下,观察到运动MDS-UPDRS和BBS得分的显著改善.
- 姿势参数显示出改善,特别是在OFF状态下,与减少的干摆动.
- 双重任务行走证明了立场时间的减少 (开启和关闭) 和行走速度的增加 (开启),后腿摇摆与双重任务条件下的立场时间正相关.
结论:
- 有氧强度运动有效地提高了PD患者的姿势稳定性和双重任务步行表现,在OFF药物状态下观察到显著的好处.
- 在不同的任务下,姿势和步态变化之间的明显相关性表明任务对运动功能的特定影响.
- 研究结果强调了定制的运动干预措施和评估策略对于优化帕金森病运动结果的重要性.
相关概念视频
Parkinson's Disease: Treatment
389
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
389
Parkinson's Disease: Overview
718
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
718


